Atlas Trials

Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus

Clinical trial NCT02283359 · TERMINATED

Trial details

NCT number
NCT02283359
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal CancerGastric Cancer
Start date
2014-12-01
Primary completion
2015-12-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.